[1]Patent:WO2009/55077,2009,A1.Locationinpatent:Page/Pagecolumn384
[2]Patent:WO2017/35408,2017,A1.Locationinpatent:Paragraph0773
[1]CurrentPatentAssignee:SUZHOUALPHAMABIOTECHNOLOGY;SUZHOUAERMAIBIOTECHNOLOGY-CN113173924,2021,A
113520-43-7
34956-29-1
42288-55-1
1208084-47-2 | 6-Bromoimidazo[1,2-a]pyrazine-3-carbaldehyde | AA0091ZF | MFCD11040201
1187932-37-1 | 2-(5-Trifluoromethyl-pyridin-2-yl)-ethylamine dihydrochloride | AA0092BR | MFCD09701351
1119499-74-9 | 1-(2,2-Difluoro-ethyl)-piperidin-4-ylamine | AA0092O5 | MFCD10699009
1070879-46-7 | 4-Bromo-6-ethoxy-2-methylquinoline | AA0093BJ | MFCD11505131
106898-37-7 | 5-Amino-1-(pyridin-4-yl)-1H-pyrazole-4-carbonitrile | AA0093P0 | MFCD09703274
1019532-16-1 | 1-Bromo-2-fluoro-3-(cyclopentylaminomethyl)benzene | AA0093ZB | MFCD11139796
1020917-27-4 | 6-Amino-3-chloropicolinic acid | AA00946I | MFCD11147705
1187586-58-8 | Montelukast EP IMpurity E | AA0094AM
117860-55-6 | 3-(Methoxycarbonyl)-1-methyl-1H-pyrazole-5-carboxylic acid | AA0094NH | MFCD15143226
120039-18-1 | 8-Methoxy-3-Methyl-1H-benzo[d]azepin-2(3H)-one | AA00951L | MFCD17169966